{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-146454","form_type":"8-K","ticker":"FNCHQ","cik":"0001733257","company_name":"Finch Therapeutics Group, Inc.","filed_at":"2024-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.800361+00:00","generated_at":"2026-06-01T08:46:28.295948+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Finch Therapeutics receives Nasdaq delisting notice; trading suspended May 28","bullets":["Nasdaq Listing Panel determined to delist Finch; company deemed a 'public shell' without an operating business.","Trading of common stock suspended at opening on May 28, 2024; Nasdaq will file Form 25-NSE after 45 days.","Common stock expected to trade on OTC market, but no assurance of prompt or continued trading."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-146454","json":"https://secwatch.observer/filing/0001193125-24-146454.json","markdown":"https://secwatch.observer/filing/0001193125-24-146454.md","text":"https://secwatch.observer/filing/0001193125-24-146454.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1733257/000119312524146454/0001193125-24-146454-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1733257/000119312524146454/d818218d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T08:46:28.295948+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}